Skip to Content

B 793 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint B 793 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 793

Rivastigmine tartrate 1.5 mg B 793

Rivastigmine Tartrate

Imprint
B 793
Strength
1.5 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0793

Get help with Imprint Code FAQs.

Related Images for "B 793"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.